India to Colombia: Docetaxel Export Trade Route

The India to Colombia Docetaxel corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $1.4M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $31.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 32.8%, placing it at rank #10 among India's top docetaxel export destinations globally.

On the import side, key buyers of Indian docetaxel in Colombia include FRESENIUS KABI COLOMBIA SAS, FRESENIUS KABI COLOMBIA SAS , ROPSOHN THERAPEUTICS SAS and 6 others. FRESENIUS KABI COLOMBIA SAS is the single largest importer with 21 shipments valued at $843.7K USD.

India's docetaxel exports to Colombia are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , VENUS REMEDIES LIMITED — together account for 89% of total trade value on this route. The average shipment value of $31.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as docetaxel inj 80mg/4ml vial batch no.87240485ba, mfg. dt. 11/2024, exp. dt. 10/2026 and docetaxel injection 80mg/4ml vial batch , suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI COLOMBIA SAS is the largest importer with 21 shipments worth $843.7K USD — representing 61% of all docetaxel imports from India on this route. A total of 9 buyers are active on this corridor.